Reported Earnings • Jun 26
Full year 2026 earnings released: EPS: RM0.45 (vs RM0.35 in FY 2025) Full year 2026 results: EPS: RM0.45 (up from RM0.35 in FY 2025). Revenue: RM127.6m (down 7.8% from FY 2025). Net income: RM48.9m (up 29% from FY 2025). Profit margin: 38% (up from 27% in FY 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year. Reported Earnings • Mar 27
Third quarter 2026 earnings released: EPS: RM0.12 (vs RM0.015 in 3Q 2025) Third quarter 2026 results: EPS: RM0.12 (up from RM0.015 in 3Q 2025). Revenue: RM24.6m (down 7.2% from 3Q 2025). Net income: RM13.0m (up RM11.3m from 3Q 2025). Profit margin: 53% (up from 6.2% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 8% per year. Reported Earnings • Dec 23
Second quarter 2026 earnings released: EPS: RM0.12 (vs RM0.16 in 2Q 2025) Second quarter 2026 results: EPS: RM0.12 (down from RM0.16 in 2Q 2025). Revenue: RM34.7m (down 5.2% from 2Q 2025). Net income: RM12.6m (down 28% from 2Q 2025). Profit margin: 36% (down from 48% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 9% per year. Annonce • Oct 23
Analabs Resources Berhad Announces Clifton Heath Fernandez Withdraws His Offer for Re-Election and Retires from Office as Director Analabs Resources Berhad announced that Clifton Heath Fernandez has withdrawn his offer for re-election and retired from office as Director of the Company at the close of 27th Annual General Meeting in accordance with Clause 119 of the Company’s Constitution. Reported Earnings • Sep 26
First quarter 2026 earnings released: EPS: RM0.01 (vs RM0.051 in 1Q 2025) First quarter 2026 results: EPS: RM0.01 (down from RM0.051 in 1Q 2025). Revenue: RM21.7m (down 33% from 1Q 2025). Net income: RM1.08m (down 81% from 1Q 2025). Profit margin: 5.0% (down from 17% in 1Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Annonce • Aug 28
Analabs Resources Berhad, Annual General Meeting, Oct 23, 2025 Analabs Resources Berhad, Annual General Meeting, Oct 23, 2025, at 11:00 Singapore Standard Time. Location: ar11, level 1, wyndham acmar klang hotel, no. 1-g-1, persiaran bukit raja 2/ku1, bandar baru klang, 41150 klang, selangor darul ehsan, Malaysia Reported Earnings • Jun 27
Full year 2025 earnings released: EPS: RM0.34 (vs RM0.25 in FY 2024) Full year 2025 results: EPS: RM0.34 (up from RM0.25 in FY 2024). Revenue: RM129.7m (down 15% from FY 2024). Net income: RM36.9m (up 33% from FY 2024). Profit margin: 28% (up from 18% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 30
Third quarter 2025 earnings released: EPS: RM0.015 (vs RM0.026 in 3Q 2024) Third quarter 2025 results: EPS: RM0.015 (down from RM0.026 in 3Q 2024). Revenue: RM26.5m (down 34% from 3Q 2024). Net income: RM1.65m (down 41% from 3Q 2024). Profit margin: 6.2% (down from 7.0% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Reported Earnings • Dec 31
Second quarter 2025 earnings released: EPS: RM0.16 (vs RM0.12 in 2Q 2024) Second quarter 2025 results: EPS: RM0.16 (up from RM0.12 in 2Q 2024). Revenue: RM36.6m (down 19% from 2Q 2024). Net income: RM17.4m (up 34% from 2Q 2024). Profit margin: 48% (up from 29% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 12% per year. Upcoming Dividend • Nov 27
Upcoming dividend of RM0.04 per share Eligible shareholders must have bought the stock before 04 December 2024. Payment date: 30 December 2024. Payout ratio is a comfortable 7.8% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Malaysian dividend payers (4.9%). Lower than average of industry peers (2.3%). Reported Earnings • Sep 24
First quarter 2025 earnings released: EPS: RM0.051 (vs RM0.036 in 1Q 2024) First quarter 2025 results: EPS: RM0.051 (up from RM0.036 in 1Q 2024). Revenue: RM32.2m (down 16% from 1Q 2024). Net income: RM5.56m (up 42% from 1Q 2024). Profit margin: 17% (up from 10% in 1Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 15% per year. Annonce • Aug 27
Analabs Resources Berhad, Annual General Meeting, Oct 10, 2024 Analabs Resources Berhad, Annual General Meeting, Oct 10, 2024, at 11:00 Singapore Standard Time. Location: lot 750, jalan haji sirat, 42100 klang, selangor darul ehsan, Malaysia Reported Earnings • Jun 28
Full year 2024 earnings released: EPS: RM0.25 (vs RM0.21 in FY 2023) Full year 2024 results: EPS: RM0.25 (up from RM0.21 in FY 2023). Revenue: RM152.5m (up 14% from FY 2023). Net income: RM27.7m (up 19% from FY 2023). Profit margin: 18% (in line with FY 2023). Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 17% per year. Reported Earnings • Mar 28
Third quarter 2024 earnings released: EPS: RM0.026 (vs RM0.012 in 3Q 2023) Third quarter 2024 results: EPS: RM0.026 (up from RM0.012 in 3Q 2023). Revenue: RM39.9m (up 13% from 3Q 2023). Net income: RM2.78m (up 117% from 3Q 2023). Profit margin: 7.0% (up from 3.6% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 15% per year. Upcoming Dividend • Feb 16
Upcoming dividend of RM0.021 per share Eligible shareholders must have bought the stock before 23 February 2024. Payment date: 22 March 2024. Payout ratio is a comfortable 6.9% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Malaysian dividend payers (4.8%). Lower than average of industry peers (3.2%). Annonce • Jan 21
Analabs Resources Berhad Declares an Single Tier Interim Dividend for the Financial Year Ending 30 April 2024, Payable on 22 March 2024 Analabs Resources Berhad declared an Single tier Interim dividend of 2 sen per ordinary share for the financial year ending 30 April 2024.Ex-Date is 23 Feb. 2024, Entitlement date is 26 Feb. 2024 and Payment Date is 22 March 2024. New Risk • Dec 29
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 19% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RM166.7m market cap, or US$36.3m). Annonce • Dec 29
Analabs Resources Berhad Reports Write Offs for the Quarter Ended October 31, 2023 Analabs Resources Berhad reported write offs for the quarter ended October 31, 2023. for the quarter, the company reported Plant and equipment written off of MYR 2,000. Annonce • Dec 28
Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2024 On 28 December 2023, Analabs Resources Berhad declared an interim dividend of 2.1 sen per ordinary share for the financial year ending 30 April 2024. Annonce • Dec 06
Analabs Resources Berhad Appoints Mr. Ling Hua Kang as Independent and Non Executive Independent Director Analabs Resources Berhad appointed Mr. Ling Hua Kang as Independent and Non Executive Independent Director, his Age is 50. Date of change is 06 December 2023. Professional Qualification is CPA AUSTRALIA ASCPA as Masters Masters of Business (Finance) from RMIT University, Melbourne. Working experience and occupation Mr. Ling Hua Kang (Mr Ling) is an experienced chartered accountant with 20 over years of working expertise in audit, corporate finance and advisory, risk management, regulatory compliance and governance. He graduated from RMIT University, Melbourne with a Masters of Finance and Bachelor of Business (Accountancy). He is also a Certified Professional Accountant and a member of CPA Australia. He is the currently the Director of Integ Success Agency and General Manager of Wells Risk Assured Holdings Sdn Bhd. Wells Global Solutions Sdn Bhd and Integ Success are one stop centres providing comprehensive coverage and tailored risk management strategies to meet the diverse needs of businesses. Prior to that, he joined BIB Insurance Brokers Sdn. Bhd. in January 2013 as a Manager in Client Servicing and Development Unit. During his tenure, he served a diversified portfolio of clients. Mr. Ling also served as General Manager in Corporate Affairs & Business Development and Project Management in Esthetics International Group Berhad (Esthetics) from January 2005 to December 2012. Mr. Ling was appointed as Vice President of Business Developments in Hwang-DBS Securities Berhad ("Hwang-DBS") in November 1999 and remained in the position until December 2004. In Hwang-DBS, Mr. Ling assisted in corporate advisory services, corporate restructuring, and IPO exercises. Reported Earnings • Sep 04
Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022) Full year 2023 results: EPS: RM0.21 (down from RM0.27 in FY 2022). Revenue: RM133.4m (up 15% from FY 2022). Net income: RM23.2m (down 21% from FY 2022). Profit margin: 17% (down from 25% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Annonce • Aug 29
Analabs Resources Berhad, Annual General Meeting, Oct 04, 2023 Analabs Resources Berhad, Annual General Meeting, Oct 04, 2023, at 11:00 Singapore Standard Time. Location: Royal Ballroom of the Kelab Golf Sultan Abdul Aziz Shah No. 1, Rumah Kelab Jalan Kelab Golf 13/6 40100 Shah Alam SELANGOR DARUL EHSAN Malaysia Agenda: To lay the audited financial statements together with the reports of the Directors and Auditors for the financial year ended 30 April 2023; to re-elect Kan Yow Kheong who retires in accordance with Clause 119 of the Company's Constitution; to re-elect Kan Mun Hoow who retires in accordance with Clause 119 of the Company's Constitution; to re-appoint Crowe Malaysia PLT as Auditors of the Company and to authorise the Directors to fix their remuneration; and to discuss other matters. Reported Earnings • Jun 28
Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022) Full year 2023 results: EPS: RM0.21 (down from RM0.27 in FY 2022). Revenue: RM136.1m (up 16% from FY 2022). Net income: RM23.2m (down 21% from FY 2022). Profit margin: 17% (down from 25% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 29
Third quarter 2023 earnings released: EPS: RM0.012 (vs RM0.098 in 3Q 2022) Third quarter 2023 results: EPS: RM0.012 (down from RM0.098 in 3Q 2022). Revenue: RM35.3m (up 6.0% from 3Q 2022). Net income: RM1.28m (down 88% from 3Q 2022). Profit margin: 3.6% (down from 32% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Feb 17
Upcoming dividend of RM0.02 per share at 1.4% yield Eligible shareholders must have bought the stock before 24 February 2023. Payment date: 10 March 2023. Payout ratio is a comfortable 10% but the company is not cash flow positive. Trailing yield: 1.4%. Lower than top quartile of Malaysian dividend payers (5.0%). Lower than average of industry peers (5.8%). Annonce • Feb 11
Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2023, Payable on 10 March 2023 Analabs Resources Berhad announced that the Board of Directors of the Company has declared a single tier interim dividend of 2 sen per ordinary share in respect of the financial year ending 30 April 2023. Ex-Date is 24 February 2023, Entitlement date is 27 February 2023 and Payment Date is 10 March 2023. Reported Earnings • Dec 17
Second quarter 2023 earnings released: EPS: RM0.051 (vs RM0.063 in 2Q 2022) Second quarter 2023 results: EPS: RM0.051 (down from RM0.063 in 2Q 2022). Revenue: RM35.7m (up 22% from 2Q 2022). Net income: RM5.52m (down 20% from 2Q 2022). Profit margin: 15% (down from 24% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Annonce • Dec 17
Analabs Resources Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 30 April 2023 Analabs Resources Berhad announced that the Board of Directors of the Company has declared a single tier interim dividend of 2 sen per ordinary share in respect of the financial year ending 30 April 2023. Board Change • Sep 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. Independent & Non Executive Director Yee Chia was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Annonce • Aug 30
Analabs Resources Berhad, Annual General Meeting, Oct 05, 2022 Analabs Resources Berhad, Annual General Meeting, Oct 05, 2022, at 11:00 Singapore Standard Time. Location: Royal Ballroom of the Kelab Golf Sultan Abdul Aziz Shah, No. 1 Rumah Kelab Jalan Kelab Golf 13/6, 40100 Shah Alam SELANGOR DARUL EHSAN Malaysia Agenda: To lay the audited financial statements together with the reports of the Directors and Auditors for the financial year ended 30 April 2022; to re-elect the Directors; to approve the payment of Directors' Fee up to RM108,000 in respect of the financial year ending 30 April 2023; to re-appoint Crowe Malaysia PLT as Auditors of the Company and to authorize the Directors to fix their remuneration; to consider proposal of Renewal of Authority for the Purchase by the Company of its own Ordinary Shares; and to transact other matters. Reported Earnings • Jun 30
Full year 2022 earnings released: EPS: RM0.27 (vs RM0.15 in FY 2021) Full year 2022 results: EPS: RM0.27 (up from RM0.15 in FY 2021). Revenue: RM117.6m (flat on FY 2021). Net income: RM29.5m (up 80% from FY 2021). Profit margin: 25% (up from 14% in FY 2021). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Annonce • May 10
Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Director Analabs Resources Berhad announced appointment of Chia Yee Yan as Independent and Non Executive Director. The date of change is May 9, 2022. Chia Yee Yan was instrumental in developing both offline and online marketing plans to establish a brand identity and also strengthen the company's reputation to stand out from competition. She has managed the distributorship for customers in the South East Asia region for the past 3 years. She is currently actively involved in the brand management for a newly started-up body care product in Malaysia. Apart from that, she is also involved in the accounting and administrative aspects of a company that is involved in fashion apparel. Annonce • Apr 01
Analabs Resources Berhad Re-Designates Kan Mun Hoow as Chief Executive Officer, Effective from 1 April 2022 Analabs Resources Berhad announced that Mr. Kan Mun Hoow has been re-designated from his existing position as Executive Director to Chief Executive Officer with effect from 1 April 2022. Mr. Kan Mun Hoow, was appointed to the Board of Directors of Analabs Resources Berhad (Analabs) as the Executive Director on 9 March 2017. He graduated with a degree in Mechanical Engineering (Hons) in year 2002 from Western Michigan University, USA. Upon completion of his studies, he joined Resources Conservation Sdn. Bhd. (RCSB) as a Junior Engineer from year 2002 to 2007. Reported Earnings • Mar 28
Third quarter 2022 earnings released: EPS: RM0.098 (vs RM0.051 in 3Q 2021) Third quarter 2022 results: EPS: RM0.098 (up from RM0.051 in 3Q 2021). Revenue: RM33.4m (up 1.3% from 3Q 2021). Net income: RM10.6m (up 92% from 3Q 2021). Profit margin: 32% (up from 17% in 3Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Feb 17
Upcoming dividend of RM0.02 per share Eligible shareholders must have bought the stock before 24 February 2022. Payment date: 11 March 2022. Payout ratio is a comfortable 9.3% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Malaysian dividend payers (4.3%). Lower than average of industry peers (3.1%). Annonce • Jan 30
Analabs Resources Berhad Announces Single-Tier Interim Dividend for the Period Ending April 30, 2022, Payable on March 11, 2022 Analabs Resources Berhad announced a single-tier Interim dividend of 2 sen per ordinary share for the period ending April 30, 2022. Ex-date is on February 24, 2022, and the payment date is on March 11, 2022. Reported Earnings • Dec 19
Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations Second quarter 2022 results: EPS: RM0.063 (up from RM0.022 in 2Q 2021). Revenue: RM29.2m (up 8.7% from 2Q 2021). Net income: RM6.86m (up 188% from 2Q 2021). Profit margin: 24% (up from 8.9% in 2Q 2021). The increase in margin was primarily driven by lower expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Reported Earnings • Sep 05
Full year 2021 earnings released: EPS RM0.15 (vs RM0.067 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM117.5m (up 6.0% from FY 2020). Net income: RM16.4m (up 126% from FY 2020). Profit margin: 14% (up from 6.5% in FY 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 30
Full year 2021 earnings released The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM117.5m (up 6.0% from FY 2020). Net income: RM16.4m (up 126% from FY 2020). Profit margin: 14% (up from 6.5% in FY 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 4% per year. Reported Earnings • Mar 27
Third quarter 2021 earnings released: EPS RM0.051 (vs RM0.012 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM32.9m (up 8.9% from 3Q 2020). Net income: RM5.55m (up 328% from 3Q 2020). Profit margin: 17% (up from 4.3% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 3% per year. Is New 90 Day High Low • Mar 04
New 90-day low: RM1.10 The company is down 5.0% from its price of RM1.16 on 02 December 2020. The Malaysian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 1.0% over the same period. Is New 90 Day High Low • Feb 08
New 90-day high: RM1.19 The company is up 8.0% from its price of RM1.10 on 09 November 2020. The Malaysian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 12% over the same period. Reported Earnings • Dec 17
Second quarter 2021 earnings released: EPS RM0.022 The company reported a poor second quarter result with weaker earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: RM26.9m (down 11% from 2Q 2020). Net income: RM2.38m (down 16% from 2Q 2020). Profit margin: 8.9% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Oct 27
New 90-day high: RM1.22 The company is up 18% from its price of RM1.03 on 29 July 2020. The Malaysian market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. Annonce • Sep 26
Analabs Resources Berhad Announces the Resignation of TAN AI PENG as Company Secretary Analabs Resources Berhad announced the Resignation of TAN AI PENG as Company Secretary. Date Of Change is 24 September 2020. Reported Earnings • Sep 25
First quarter earnings released Over the last 12 months the company has reported total profits of RM9.41m, up 98% from the prior year. Total revenue was RM108.5m over the last 12 months, down 11% from the prior year.